Unexpectedly, simultaneous coligation of the CD150 and CD180 receptors on CLL B cells led to cross-inhibition of the Akt and MAPK pathways (Fig 6). The gene discussed is SLAMF1; the disease is B-cell chronic lymphocytic leukemia.